Authors


Hal F. Yee Jr, MD, PhD

Latest:

Healthcare Reform With a Safety Net: Lessons From San Francisco

San Francisco is attempting to expand health insurance coverage and access to care while also supporting its healthcare safety net.


Adrienne Chung, PhD

Latest:

Reconsidering the Economic Value of Multiple Sclerosis Therapies

Availability of multiple sclerosis (MS) therapies provides substantial value to the currently healthy (who may contract MS in the future), particularly when treatment is fully covered by insurance.


Young-Ku Choi, PhD

Latest:

Identification of and Intervention to Address Therapeutic Gaps in Care

A program identifying and resolving care gaps involving community pharmacists resulted in increased adherence and omission gaps closure and fewer adherence gap reopenings.


Xi Tan, PharmD, PhD

Latest:

Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy

The increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.


Sidakpal Panaich, MD

Latest:

Health Literacy and Cardiovascular Disease Risk Factors Among the Elderly: A Study From a Patient-Centered Medical Home

A study to determine the health literacy of elderly patients and establish whether an association exists between health literacy and cardiovascular disease risk factors.




Shirley Beckett, AAS

Latest:

Does Telephone Scheduling Assistance Increase Mammography Screening Adherence?

The authors describe a quality improvement intervention that focuses on directly scheduling mammogram appointments for women who lack adherence despite written outreach letters.



Elizabeth Blair, MS, ANP-BC, CDE, CDTC

Latest:

CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes

From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.



Thomas M. Bashore, MD

Latest:

Health Insurance and Racial Disparities in Pulmonary Hypertension Outcomes

In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.


Sean P. Gleeson, MD, MBA

Latest:

Implications of Eligibility Category Churn for Pediatric Payment in Medicaid

Analyses of Ohio Medicaid claims data from 2013 to 2015 reveal that instability among eligibility categories is common and affects average capitation but not health service use.





Vicki Fung, PhD

Latest:

High-Risk Care Management Impact on Medicaid ACO Utilization and Spending

In Massachusetts’ largest Medicaid accountable care organization (ACO), high-risk care management significantly reduced spending, emergency department visits, and hospitalizations, demonstrating that targeted strategies can manage health care costs amid budget constraints.


Alexander C. Marshall, PharmD, MPH

Latest:

Humanistic and Economic Burden of Hepatocellular Carcinoma: Systematic Literature Review

Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.


James Baumgardner, PhD

Latest:

Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.


Michael E. Porter, PhD, MBA

Latest:

A Blueprint for Pharmacy Benefit Managers to Increase Value

Pharmacy benefit managers can increase value through promoting use of cost-effective medications, timely initiation of essential therapy, and adherence to that therapy.





C. David Klingman, PhD

Latest:

Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients

A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.






Michael Shwartz, PhD

Latest:

How Pooling Fragmented Healthcare Encounter Data Affects Hospital Profiling

Incomplete records of patient history can bias hospital profiling. Completing health records for Medicare-covered patients in VA hospitals resulted in modest changes in hospital performance.


Stoddard Davenport, BA

Latest:

Population Health in Primary Care: Cost, Quality, and Experience Impact

An evaluation of the use of predictive modeling for primary care resource allocation demonstrated reduced spending and improved quality and patient experience for publicly insured adults.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo